Search Results - "Ferre, P.J."

158P Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant OVCA by Moroney, J., Yeku, O., Fleming, G., Emens, L.A., Vaena, D., Dumbrava, E.E., Rasco, D., Sharma, M.R., Papadopoulos, K., Patnaik, A., Sullivan, R.J., Adewoye, H.H., Ophir, E., Cojocaru, G., Ferre, P.J., Izar, B., Gaillard, S.

Get full text

159P COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum-resistant epithelial ovarian cancer by Yeku, O., D. Shepard, Patel, M., Fleming, G., Vaena, D., Rasco, D., Chmielowski, B., Sharma, M.R., Hamilton, E., Sullivan, R.J., Papadopoulos, K., Izar, B., Cojocaru, G., Ophir, E., Ferre, P.J., Dumbrava, E.E.

Get full text

130P COM701 ± nivolumab: Preliminary results of antitumor activity from a phase I study in patients with metastatic NSCLC who have received prior PD-1/PD-L1 inhibitor by Sullivan, R.J., Sharma, M.R., Vaena, D., Hamilton, E., Izar, B., Rasco, D., Gainor, J., D. Shepard, Papadopoulos, K., Dumbrava, E.E., Adewoye, H.H., Ferre, P.J., Ophir, E., Patel, M., Patnaik, A., Chmielowski, B.

Get full text